AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Foliripe Tablet

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Letrozole (2.5mg)

Overview Foliripe Tablet

Postmenopausal women with breast cancer may find relief with Foliripe Tablets. This medication can be administered independently or alongside other therapies like surgery or radiotherapy. In advanced cases, it helps curb metastasis. Foliripe Tablets may be ingested with or without food; always adhere to your physician's dosage and treatment schedule for optimal results. Dosage varies based on the specific application. Your doctor will determine the appropriate amount to alleviate your symptoms, and treatment should continue as directed. Common side effects include hot flushes, tiredness, excessive perspiration, and elevated cholesterol. Report any concerning or persistent symptoms to your doctor, who can offer mitigation strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, osteoporosis, or other medications you are currently using, as interactions can influence efficacy. Disclose any pregnancy or breastfeeding status as well. Your doctor may order blood tests to monitor vitamin D levels and bone density before and throughout the course of treatment.

Uses of Foliripe Tablet

Managing breast cancer

Major Benefits of Foliripe Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Foliripe Tablets can be consumed with or without food, though consistent timing is recommended for optimal results.

Common Side effects of Foliripe Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Foliripe Tablet:

Administer Foliripe Tablet precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent daily timing is recommended.

How Foliripe Tablet works:

Foliripe tablets function as an aromatase inhibitor, reducing the body's estrogen production—a key female hormone. This lower estrogen level can impede or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Foliripe Tablet and alcohol consumption.

PregnancyPregnancyUNSAFE

Using Foliripe Tablet during pregnancy poses a substantial risk. Pregnant women should consult their physician, as research in both animals and humans indicates significant potential harm to the unborn child.

Breast feedingBreast feedingUNSAFE

Lactation and Foliripe Tablet are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking Foliripe Tablets may cause drowsiness, blurred vision, or dizziness, potentially impairing alertness. Driving while experiencing these effects is strongly discouraged.

KidneyKidneySAFE IF PRESCRIBED

Foliripe Tablet poses no known safety concerns for individuals with kidney disease, and no dosage modification is advised. Nevertheless, data regarding its use in patients with end-stage renal disease is scarce. Physician consultation is recommended.

LiverLiverCAUTION

Patients with hepatic impairment should use Foliripe Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Foliripe Tablet :

Should you forget a Foliripe Tablet dose, take it immediately. If, however, your next dose is nearly due, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Foliripe Tablet

LabelValue
Type of Compound Benzophenone-related compound
Addictive None.
Medication Category Cancer therapeutics

FAQs on Foliripe Tablet

Aromatase inhibitor Foliripe tablets are typically indicated for managing breast cancer in postmenopausal women, or those whose menstrual cycles have ceased following surgical intervention or cancer treatment.
Foliripe Tablet functions as an aromatase inhibitor, a class of medication that lowers estrogen levels. This effect stems from its inhibition of aromatase, the enzyme responsible for estrogen synthesis. Because some breast cancers, termed "estrogen-dependent cancers," rely on estrogen for growth, suppressing estrogen production can hinder tumor development.
For advanced breast cancer, or cancer that has metastasized, Foliripe Tablet should be continued until disease progression is observed. Following tamoxifen or surgery, Foliripe Tablet is prescribed for five years, or until recurrence, whichever occurs earlier. Alternatively, a sequential regimen of two years of Foliripe Tablet followed by three years of tamoxifen may be employed.
Concurrent use of irbesartan and Foliripe Tablet is permissible. Nevertheless, diligent blood pressure monitoring is advised, as Foliripe Tablet can elevate blood pressure. Seek medical attention if blood pressure management proves difficult.
While rare, Foliripe Tablet use is associated with a potential risk of cataract development. Therefore, blurred vision or eye discomfort warrants immediate medical attention.
Experiencing this may indicate hot flashes, a frequent side effect of Foliripe Tablet associated with reduced estrogen. These typically lessen as your body adapts to the medication. Nevertheless, for some, sweating and hot flashes might persist throughout treatment, subsiding only after several months. If this proves disruptive, seeking advice from your physician for appropriate management is recommended.
While rare, Foliripe Tablet may cause serious adverse reactions in some individuals. These include, but are not limited to: stroke, angina pectoris, myocardial infarction, thromboembolic events, cataracts, osteoporosis, and severe dermatological reactions.
Taking Foliripe Tablets can lead to bone thinning or loss (osteoporosis) resulting from reduced estrogen. Your physician might assess your bone density—a method for detecting osteoporosis—before, throughout, and following your treatment.
The Ministry of Health and Family Welfare designates Foliripe Tablets solely for the induction of ovulation in women experiencing anovulatory infertility.
Foliripe Tablet
146
MRP 169
13% off